What to expect in US healthcare in 2025 and beyond
Healthcare industry economics are shifting toward non-acute care delivery, healthcare software, data, analytics, and specialty pharmacy segments.
Healthcare industry economics are shifting toward non-acute care delivery, healthcare software, data, analytics, and specialty pharmacy segments.
Data from the phase 1 trial are intended to support dosing in a planned phase 2 trial in kidney transplant recipients.
Xenotransplantation offers a potential solution to the organ shortage crisis. A 62-year-old hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access…
Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price…
Parkinson’s disease (PD) is more prevalent in men than women, and presents with different clinical features in each sex. Despite widespread recognition of these differences,…
Dr. Pescatello is Distinguished Professor of Kinesiology at the University of Connecticut (UConn). She holds joint appointments in the Departments of Allied …
Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.
Health-tech startup Babynama secures $700K to advance digital paediatric solutions
HLH, a cytokine-mediated hyperinflammation syndrome, causes fever, pancytopenia, and hemophagocytosis and is often fatal. Antiinflammatory agents, etoposide, and interferon-γ antibody are the main …
This e-book provides information about the advantages and disadvantages of different activity tracking solutions in research use. The guide is not a systematic review but…
French healthcare company Sanofi announced on Friday a share buyback plan worth up to 2 billion euros ($2.1 billion), which would be done between now…